Paperpal Prime Logo

Antibodies : Impact Factor & More

eISSN: 2073-4468pISSN: 2073-4468
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Antibodies

Antibodies Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Multidisciplinary Digital Publishing Institute (MDPI)
Language English
Frequency Quarterly
Article Processing ChargesCHF 1600
Publication Time6
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Antibodies ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Antibodies

Characterization of Anti-Phospholipid Antibodies in Lyme Borreliosis Using In-House Developed ELISAs.
  • 22 Jun 2026
  • Antibodies (Basel, Switzerland)
Anti-Type I Interferon Autoantibodies in COVID-19 and Systemic Lupus Erythematosus: A Comparative Review.
  • 17 Jun 2026
  • Antibodies (Basel, Switzerland)
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review.
  • 16 Jun 2026
  • Antibodies (Basel, Switzerland)
The Shifting Paradigm of Monoclonal Antibodies in COVID-19 Management: From Early Triumphs to Viral Resistance and Future Perspectives.
  • 11 Jun 2026
  • Antibodies (Basel, Switzerland)
Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa.
  • 29 May 2026
  • Antibodies (Basel, Switzerland)
From Single Cells to Silicon: Emerging Technologies Transforming Monoclonal Antibody Discovery.
  • 29 May 2026
  • Antibodies (Basel, Switzerland)
Characterization of Anti-Phospholipid Antibodies in Lyme Borreliosis Using In-House Developed ELISAs.
  • 22 Jun 2026
  • Antibodies (Basel, Switzerland)
Anti-Type I Interferon Autoantibodies in COVID-19 and Systemic Lupus Erythematosus: A Comparative Review.
  • 17 Jun 2026
  • Antibodies (Basel, Switzerland)
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review.
  • 16 Jun 2026
  • Antibodies (Basel, Switzerland)
The Shifting Paradigm of Monoclonal Antibodies in COVID-19 Management: From Early Triumphs to Viral Resistance and Future Perspectives.
  • 11 Jun 2026
  • Antibodies (Basel, Switzerland)
Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa.
  • 29 May 2026
  • Antibodies (Basel, Switzerland)
From Single Cells to Silicon: Emerging Technologies Transforming Monoclonal Antibody Discovery.
  • 29 May 2026
  • Antibodies (Basel, Switzerland)

FAQs on Antibodies